Linked Data API

Show Search Form

Search Results

170406
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-12-15
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Bladder Cancer: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, pursuant to the Answer of 15 December 2014 to Question 217880, if he will estimate the number of patients with bladder cancer who have had treatment delayed due to a shortage of Bacillus Calmette-Guérin drugs, including OncoTICE. more like this
tabling member constituency Kilmarnock and Loudoun more like this
tabling member printed
Cathy Jamieson more like this
uin 218859 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-18more like thismore than 2014-12-18
answer text <p>The Department does not hold centrally information on the number of patients whose treatment for bladder cancer will be affected, or whether patients currently receiving Bacillus Calmette-Guérin treatment for bladder cancer have had their treatment suspended because of a shortage of vaccine supplies.</p><p> </p><p> </p><p> </p><p>We are working closely with the suppliers to help ensure that supplies are available for United Kingdom patients. We are also in close contact with the British Association of Urological Surgeons who have issued advice for clinicians.</p><p> </p><p> </p><p> </p> more like this
answering member constituency Mid Norfolk remove filter
answering member printed George Freeman more like this
question first answered
less than 2014-12-18T15:42:46.357Zmore like thismore than 2014-12-18T15:42:46.357Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4011
label Biography information for Cathy Jamieson more like this
170408
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-12-15
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading NHS: Finance more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many individual funding requests have been made to NHS England in each month since April 2013; and how many have of those been refused. more like this
tabling member constituency Denton and Reddish more like this
tabling member printed
Andrew Gwynne more like this
uin 218832 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-18more like thismore than 2014-12-18
answer text <p>The information requested is shown in the table.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Month</p></td><td><p>Total number of individual funding requests received</p></td><td><p>Total number of requests declined</p></td></tr><tr><td><p>April 2013</p></td><td><p>490</p></td><td><p>88</p></td></tr><tr><td><p>May 2013</p></td><td><p>719</p></td><td><p>108</p></td></tr><tr><td><p>June 2013</p></td><td><p>510</p></td><td><p>69</p></td></tr><tr><td><p>July 2013</p></td><td><p>513</p></td><td><p>99</p></td></tr><tr><td><p>August 2013</p></td><td><p>423</p></td><td><p>65</p></td></tr><tr><td><p>September 2013</p></td><td><p>345</p></td><td><p>68</p></td></tr><tr><td><p>October 2013</p></td><td><p>442</p></td><td><p>98</p></td></tr><tr><td><p>November 2013</p></td><td><p>350</p></td><td><p>86</p></td></tr><tr><td><p>December 2013</p></td><td><p>330</p></td><td><p>49</p></td></tr><tr><td><p>January 2014</p></td><td><p>362</p></td><td><p>62</p></td></tr><tr><td><p>February 2014</p></td><td><p>323</p></td><td><p>51</p></td></tr><tr><td><p>March 2014</p></td><td><p>316</p></td><td><p>54</p></td></tr><tr><td><p>April 2014</p></td><td><p>304</p></td><td><p>41</p></td></tr><tr><td><p>May 2014</p></td><td><p>338</p></td><td><p>56</p></td></tr><tr><td><p>June 2014</p></td><td><p>314</p></td><td><p>41</p></td></tr><tr><td><p>July 2014</p></td><td><p>358</p></td><td><p>74</p></td></tr><tr><td><p>August 2014</p></td><td><p>309</p></td><td><p>56</p></td></tr><tr><td><p>September 2014</p></td><td><p>296</p></td><td><p>50</p></td></tr><tr><td><p>October 2014</p></td><td><p>306</p></td><td><p>72</p></td></tr><tr><td><p>November 2014</p></td><td><p>246</p></td><td><p>38</p></td></tr></tbody></table><p> </p><p><em>Source: </em>NHS England</p><p> </p><p> </p><p> </p><p>This information does not include applications for cancer medicines as these are either routinely commissioned or handled via the Cancer Drugs Fund. NHS England publishes quarterly information on the number of individual Cancer Drugs Fund applications, including those refused. This information is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/ourwork/pe/cdf/" target="_blank">www.england.nhs.uk/ourwork/pe/cdf/</a></p><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency Mid Norfolk remove filter
answering member printed George Freeman more like this
question first answered
less than 2014-12-18T17:06:11.663Zmore like thismore than 2014-12-18T17:06:11.663Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1506
label Biography information for Andrew Gwynne more like this
170414
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-12-15
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Prescription Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, pursuant to the Answer of 8 December 2014 to Question 216568, what discussions his Department had with patient groups other than Breast Cancer Campaign, when developing its response to the Off-patent Drugs Bill. more like this
tabling member constituency Knowsley more like this
tabling member printed
Mr George Howarth more like this
uin 218845 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-06more like thismore than 2015-01-06
answer text <p>We have had no other discussions with patient groups other than Breast Cancer Campaign. The Bill raises a number of issues and we will be discussing these at a roundtable stakeholder event in the new year, to which a broader range of patient groups will be invited.</p><p> </p> more like this
answering member constituency Mid Norfolk remove filter
answering member printed George Freeman more like this
question first answered
less than 2015-01-06T14:56:34.303Zmore like thismore than 2015-01-06T14:56:34.303Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
481
label Biography information for Sir George Howarth more like this
170423
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-12-15
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading NHS: Transatlantic Trade and Investment Partnership more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what assessment he has made of the potential effect of agreement on the Transatlantic Trade and Investment Partnership on (a) service delivery and (b) costs in the NHS. more like this
tabling member constituency Esher and Walton more like this
tabling member printed
Mr Dominic Raab more like this
uin 218765 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-18more like thismore than 2014-12-18
answer text <p>The Transatlantic Trade and Investment Partnership (TTIP) will not affect the way the United Kingdom Government runs the National Health Service. It has been made clear by negotiators from both the United States and the European Union that it is up to the UK alone to decide how the NHS is run and any assertion that TTIP will undermine the government’s control of the NHS is a red herring.</p><p> </p><p> </p><p> </p><p>The TTIP could offer great benefits to British business and for British jobs. Greater consistency in existing and new regulatory requirements would make it easier for companies - especially Small and Medium Enterprises - to access markets and, for patients, potentially help to increase access to new medicines and medical devices.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> more like this
answering member constituency Mid Norfolk remove filter
answering member printed George Freeman more like this
question first answered
less than 2014-12-18T16:57:00.887Zmore like thismore than 2014-12-18T16:57:00.887Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4007
label Biography information for Dominic Raab more like this
170426
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-12-15
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Cancer: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what proportion of Individual Funding Requests for cancer medicines were approved in (a) 2011-12, (b) 2012-13 and (c) 2013-14. more like this
tabling member constituency Redditch more like this
tabling member printed
Karen Lumley more like this
uin 218736 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-05more like thismore than 2015-01-05
answer text <p>Prior to April 2013, Individual Funding Requests were administered through primary care trusts and information on the numbers of such requests was not collected centrally.</p><p> </p><p> </p><p> </p><p>Since April 2013, cancer medicines are either routinely commissioned by NHS England or funded through the Cancer Drugs Fund.</p><p> </p><p> </p><p> </p><p>NHS England publishes quarterly information on the number of individual Cancer Drugs Fund applications, including those refused by the Cancer Drugs Fund panel. This information is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/ourwork/pe/cdf/" target="_blank">www.england.nhs.uk/ourwork/pe/cdf/</a></p><p> </p> more like this
answering member constituency Mid Norfolk remove filter
answering member printed George Freeman more like this
question first answered
less than 2015-01-05T13:07:05.137Zmore like thismore than 2015-01-05T13:07:05.137Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4023
label Biography information for Karen Lumley more like this
170429
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-12-15
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, pursuant to the Answer of 5 December 2014 to Question 216943, whether he plans to include issues related to off-patent drugs in the Innovative Medicines and MedTech Review. more like this
tabling member constituency Newcastle upon Tyne North more like this
tabling member printed
Catherine McKinnell more like this
uin 218729 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-18more like thismore than 2014-12-18
answer text <p>The terms of reference of the Innovative Medicines and MedTech Review are still being developed. As set out in a Written Ministerial Statement on 20 November 2014, we expect this to focus on the most innovative medicines, devices and diagnostics which would include innovative use of existing medicine. Where appropriate this may cover off patent medicines, but final decisions on scope have not yet been taken. A link to the statement is provided:</p><p> </p><p> </p><p> </p><p><a href="http://www.parliament.uk/documents/commons-vote-office/November%202014/20%20November/2-Health-InnovativeMedicines.pdf" target="_blank">http://www.parliament.uk/documents/commons-vote-office/November%202014/20%20November/2-Health-InnovativeMedicines.pdf</a></p><p> </p><p> </p><p> </p> more like this
answering member constituency Mid Norfolk remove filter
answering member printed George Freeman more like this
question first answered
less than 2014-12-18T17:35:55.133Zmore like thismore than 2014-12-18T17:35:55.133Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4125
label Biography information for Catherine McKinnell more like this
170430
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-12-15
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, pursuant to the Answer of 5 December 2014 to Question 216943, whether the statement that off-patent drugs are widely used in the NHS refers to the use of off-patent drugs outside of their licensed indications. more like this
tabling member constituency Newcastle upon Tyne North more like this
tabling member printed
Catherine McKinnell more like this
uin 218728 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-18more like thismore than 2014-12-18
answer text <p>Yes.</p><p> </p> more like this
answering member constituency Mid Norfolk remove filter
answering member printed George Freeman more like this
question first answered
less than 2014-12-18T17:04:13.613Zmore like thismore than 2014-12-18T17:04:13.613Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4125
label Biography information for Catherine McKinnell more like this
170440
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-12-15
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Breast Cancer: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what assessment he has made of the effect of re-evaluating the Cancer Drugs Fund list on breast cancer patients. more like this
tabling member constituency Brigg and Goole more like this
tabling member printed
Andrew Percy more like this
uin 218764 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-18more like thismore than 2014-12-18
answer text <p>I refer my hon. Friend to the Answer I gave the hon. Member for Bromley and Chislehurst (Robert Neill) on 16 December 2014 to Question <a href="http://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2014-12-09/217858/" target="_blank">217858</a></p><p> </p> more like this
answering member constituency Mid Norfolk remove filter
answering member printed George Freeman more like this
question first answered
less than 2014-12-18T17:34:50.2Zmore like thismore than 2014-12-18T17:34:50.2Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
3939
label Biography information for Andrew Percy more like this
170448
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-12-15
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading National Institute for Health and Care Excellence more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much the National Institute for Health and Care Excellence has spent on its website in the last three years. more like this
tabling member constituency Croydon North more like this
tabling member printed
Mr Steve Reed more like this
uin 218623 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-18more like thismore than 2014-12-18
answer text <p>The National Institute for Health and Care Excellence (NICE) has advised that, between April 2011 and April 2014, it spent a total of £1.66 million on its website. The majority of this spend was on staff costs as the website is now supported and maintained internally.</p><p> </p><p> </p><p> </p><p>NICE stopped printing its guidance in 2010-11, saving annual print and distribution costs of over £1 million. NICE has advised that it will continue to invest in improvements to its website as it is now the only outlet for the guidance and other products it produces.</p><p> </p><p><strong> </strong></p><p> </p> more like this
answering member constituency Mid Norfolk remove filter
answering member printed George Freeman more like this
question first answered
less than 2014-12-18T15:34:35.4Zmore like thismore than 2014-12-18T15:34:35.4Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4268
label Biography information for Steve Reed more like this
170452
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-12-15
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what discussions he has had with clinicians about how to improve the uptake of clinically and cost-effective off-patent drugs outside their licensed indications. more like this
tabling member constituency Barnsley Central more like this
tabling member printed
Dan Jarvis more like this
uin 218685 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-18more like thismore than 2014-12-18
answer text <p>We have had no detailed discussions but we are holding a roundtable stakeholder event in the new year where we will discuss a number of issues raised by the Off-Patent Drugs Bill. Individual prescribing decisions on the most appropriate treatments are a matter for clinicians, in discussion with their patients.</p><p> </p> more like this
answering member constituency Mid Norfolk remove filter
answering member printed George Freeman more like this
question first answered
less than 2014-12-18T15:44:54.17Zmore like thismore than 2014-12-18T15:44:54.17Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4243
label Biography information for Dan Jarvis more like this